← Leaderboards
Robert S Kass
Columbia University Health Sciences
$17,577,637
Attributed
$21,416,304
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$21,416,304 · 11
By mechanism
R01$16,102,740 · 5
P01$2,870,991 · 3
T32$1,528,698 · 2
S10$913,875 · 1
Top collaborators
- Hans Peter Larsson8 shared
- Arthur J. Moss4 shared
- Wojciech Zareba2 shared
- Gordana Vunjak-Novakovic1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Andrew R Marks$38,589,991
Others in their field
Top investigators on “Arrhythmia”
- Dan M Roden · Vanderbilt University Medical Center$63,173,998
- Lynn A Sleeper · New England Research Institutes, Inc.$48,939,627
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$40,886,752
- Russell E Ware · Duke University$30,715,534
- David Herlie Robertson · Vanderbilt University$28,928,663
- Henry R Halperin · Johns Hopkins University$27,245,374
Research focus
ArrhythmiaPotassium ChannelResponseAction PotentialsMutationComplexMolecularHeartLong Qt SyndromeCardiac MyocytesCardiacBaseRegulationLinkAffectSodium ChannelInheritedVoltage /Patch ClampLeadInsightMutantProteinsCyclic Amp-Dependent Protein KinasesIon Channel
Grant awards (61)
Modulation of KCNQ1 channel activity$408,318
R01 · FY2022 · GM
Modulation of KCNQ1 channel activity$408,318
R01 · FY2021 · GM
Modulation of KCNQ1 channel activity$440,956
R01 · FY2020 · GM
Modulation of KCNQ1 channel activity$469,810
R01 · FY2019 · GM
Clinical and Basic Science Studies in Long QT Syndrome Type 3$733,092
R01 · FY2018 · HL
Clinical and Basic Science Studies in Long QT Syndrome Type 3$742,812
R01 · FY2017 · HL
Modulation of KCNQ1 channel activity$329,175
R01 · FY2017 · GM
Clinical and Basic Science Studies in Long QT Syndrome Type 3$32,478
R01 · FY2017 · HL
Clinical and Basic Science Studies in Long QT Syndrome Type 3$733,092
R01 · FY2016 · HL
Modulation of KCNQ1 channel activity$329,175
R01 · FY2016 · GM
Clinical and Basic Science Studies in Long QT Syndrome Type 3$722,095
R01 · FY2015 · HL
Modulation of KCNQ1 channel activity$329,175
R01 · FY2015 · GM
Clinical and Basic Science Studies in Long QT Syndrome Type 3$742,413
R01 · FY2014 · HL
Modulation of KCNQ1 channel activity$342,550
R01 · FY2014 · GM
Molecular Determinants of K+ Channel Regulation in Heart$377,712
R01 · FY2013 · HL · contact PI
Nanion Syncro Patch 96$913,875
S10 · FY2012 · OD · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$395,998
R01 · FY2012 · HL · contact PI
Training Program in Pharmaceutical Sciences$178,618
T32 · FY2012 · GM · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$399,270
R01 · FY2011 · HL · contact PI
Molecular Pharmacology of An Inherited Heart Disease$362,250
R01 · FY2011 · HL · contact PI
Ion Channels and Sudden Cardiac Death$319,180
P01 · FY2011 · HL · contact PI
Training Program in Pharmaceutical Sciences$176,752
T32 · FY2011 · GM · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$398,576
R01 · FY2010 · HL · contact PI
Molecular Pharmacology of An Inherited Heart Disease$362,250
R01 · FY2010 · HL · contact PI
Ion Channels and Sudden Cardiac Death$326,930
P01 · FY2010 · HL · contact PI
Training Program in Pharmaceutical Sciences$174,938
T32 · FY2010 · GM · contact PI
Molecular Pharmacology of An Inherited Heart Disease$362,250
R01 · FY2009 · HL · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$343,479
R01 · FY2009 · HL · contact PI
Training Program in Pharmaceutical Sciences$174,056
T32 · FY2009 · GM · contact PI
Molecular Pharmacology of An Inherited Heart Disease$362,250
R01 · FY2008 · HL · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$343,479
R01 · FY2008 · HL · contact PI
Training Program in Pharmaceutical Sciences$173,175
T32 · FY2008 · GM · contact PI
Ion Channels and Sudden Cardiac Death$835,574
P01 · FY2007 · HL · contact PI
Molecular Pharmacology of An Inherited Heart Disease$362,250
R01 · FY2007 · HL · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$343,479
R01 · FY2007 · HL · contact PI
Molecular Determinants of K+ Channel Regulation in Heart$353,738
R01 · FY2006 · HL · contact PI
Molecular Pharmacology of An Inherited Heart Disease$319,316
R01 · FY2006 · HL · contact PI
Training Program in Pharmacological Sciences$172,317
T32 · FY2006 · GM · contact PI
Ion channels and sudden cardiac death$369,215
P01 · FY2005 · HL
Molecular Determinants of K+ Channel Regulation in Heart$362,250
R01 · FY2005 · HL
Molecular Pharmacology of An Inherited Heart Disease$327,000
R01 · FY2005 · HL
Training Program in Pharmacological Sciences$178,107
T32 · FY2005 · GM
Molecular Pharmacology of An Inherited Heart Disease$327,000
R01 · FY2004 · HL
Molecular Determinants of K+ Channel Regulation in Heart$327,000
R01 · FY2004 · HL
Molecular Pharmacology of An Inherited Heart Disease$327,000
R01 · FY2003 · HL
Molecular Determinants of K+ Channel Regulation in Heart$327,000
R01 · FY2003 · HL
Ion channels and sudden cardiac death$343,463
P01 · FY2002 · HL
Molecular Pharmacology of An Inherited Heart Disease$327,000
R01 · FY2002 · HL
Molecular Determinants of K+ Channel Regulation in Heart$327,000
R01 · FY2002 · HL
MOLECULAR TARGETING OF CA2+ AND K+ CHANNELS IN HEART$225,543
P01 · FY2002 · HL
CARDIAC ARRYTHMIAS: MECHANISMS AND TREATMENT$97,172
T32 · FY2002 · HL
Molecular Determinants of K+ Channel Regulation in Heart$327,000
R01 · FY2001 · HL
MOLECULAR PHARMACOLOGY OF AN INHERITED HEART DISEASE$260,088
R01 · FY2001 · HL
CHARGED DIHYDROPYRIDINES--PROBES OF HEART CA++ CHANNELS$240,596
R01 · FY2001 · HL
MOLECULAR TARGETING OF CA2+ AND K+ CHANNELS IN HEART$225,543
P01 · FY2001 · HL
CARDIAC ARRYTHMIAS: MECHANISMS AND TREATMENT$203,563
T32 · FY2001 · HL
Ion channels and sudden cardiac death$0
P01 · FY2001 · HL
K+ CHANNELS IN NORMAL AND GENETICALLY ALTERED HEART$284,464
R01 · FY2000 · HL
MOLECULAR PHARMACOLOGY OF AN INHERITED HEART DISEASE$254,998
R01 · FY2000 · HL
CHARGED DIHYDROPYRIDINES--PROBES OF HEART CA++ CHANNELS$234,588
R01 · FY2000 · HL
MOLECULAR TARGETING OF CA2+ AND K+ CHANNELS IN HEART$225,543
P01 · FY2000 · HL